Integrative Cancer Therapies
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.1 | Q2 | 69.4% | 0.727 | Q1 | 74.2% |
| 2024 | 2.8 | Q2 | 66.7% | 0.799 | Q1 | 77.9% |
| 2023 | 2.9 | Q2 | 50.4% | 0.687 | Q1 | 75.1% |
| 2022 | 2.9 | Q2 | 41.8% | 0.766 | Q1 | 79.3% |
| 2021 | 3.1 | Q4 | 42.9% | 0.642 | Q1 | 74.9% |
| 2020 | — | — | 0.730 | Q1 | 77.3% | |
| 2019 | — | — | 0.708 | Q1 | 77.2% | |
| 2018 | — | — | 0.806 | Q1 | 78.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1534-7354
ISSN
1552-695X
country
UScoverage
2002-2026